Genetic Mutations Drive Metastatic Castration Resistant Prostate Cancer Evolution
The genetic landscape of metastatic castration-resistant prostate cancer (mCRPC) reveals intricate molecular alterations that drive disease progression and treatment resistance. Recent research has identified crucial mutations in tumor suppressor genes and distinct epigenetic changes that contribute to the development of neuroendocrine prostate cancer, offering new insights for targeted therapeutic approaches. Key Takeaways: Genetic mutations in […]